Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating safety, tolerability, and activity of lonafarnib in combination with docetaxel (Study P04467AM1) was terminated, involving patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastric Cancer
• Lung Cancer
• Ovarian Cancer
• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Lonafarnib (lonafarnib)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Prostate Cancer, Breast Cancer | Phase 1, Phase 2 | Status: TERMINATED